Influenza Virus Infection of an Immunocompetent Organotypic Model of the Human Respiratory Mucosa

The study establishes a physiologically relevant, immunocompetent 3D organotypic model of the human respiratory mucosa that successfully supports influenza A virus replication and enables the monitoring of early antiviral innate immune responses.

The Gist

Imagine your nose isn't just a hole for breathing; it's a bustling, high-tech fortress. It has a outer wall (the skin-like cells), a security team (immune cells), and a sticky, moving carpet (mucus and hair-like cilia) designed to sweep away invaders.

For a long time, scientists studying viruses like the flu have been trying to build a "mini-nose" in a petri dish to see how these attacks happen. But their old models were like empty fortresses: they had the outer wall, but they were missing the security team and the structural support underneath. They were good, but they didn't tell the whole story.

This paper introduces a brand new, super-realistic "Mini-Nose" model that finally includes all the missing pieces. Here's how they built it and what they found, explained simply:

1. Building the "Mini-Nose" (The Construction)

Instead of just growing a flat layer of cells, the scientists built a 3D structure that mimics the real thing, layer by layer. Think of it like building a suspension bridge:

• The Foundation (The Scaffold): They used a special sponge made of collagen (a protein found in our skin) and chitosan (a natural material from shrimp shells). This acts as the steel beams and concrete of the bridge.
• The Support Crew (Fibroblasts): First, they planted "construction workers" (fibroblasts) into the sponge. These cells are like the architects that build the scaffolding and keep the structure strong. They let them work for weeks to build a solid base.
• The Security Team (Macrophages): Next, they added the "security guards" (macrophages). These are immune cells that patrol the area, looking for trouble. In previous models, this team was missing. Here, they are embedded right inside the sponge, ready to react.
• The Outer Wall (Epithelial Cells): Finally, they grew the actual "skin" of the nose on top. These cells grew into a complex layer with different types:
  • Basal cells: The stem cells at the bottom that act as the foundation.
  • Ciliated cells: Cells with tiny, hair-like arms that wave back and forth to sweep dust and germs away.
  • Goblet cells: Cells that produce mucus (the sticky trap).

The Result: A living, breathing 3D nose that looks and acts almost exactly like the real thing, complete with a "security team" living inside the walls.

2. The Test: Invading with the Flu

To see if their new model worked, they decided to stage a "drill." They infected the mini-noses with the Influenza A virus (the flu).

• The Attack: They dropped the virus onto the top of the model (just like you breathe it in).
• The Reaction: The model reacted exactly like a real human nose would.
  • The virus successfully infected the cells and started multiplying.
  • The "security guards" (macrophages) and the "construction workers" (fibroblasts) sounded the alarm.
  • The model started pumping out interferons (chemical distress signals) and inflammatory cytokines (the body's "alert" chemicals) to fight back.

3. The Big Surprise

The scientists wanted to see if having the "security guards" (macrophages) inside the model changed how the virus behaved.

• The Expectation: They thought the security guards might stop the virus faster or change the battle significantly.
• The Reality: Surprisingly, the virus multiplied just as much whether the guards were there or not. The guards did react, but the main fighters in this early stage were actually the wall cells (epithelial cells) and the construction workers (fibroblasts). The guards were there, but they hadn't fully "woken up" to change the outcome of the initial battle in this specific setup.

Why Does This Matter?

Think of this new model as a flight simulator for viruses.

• Old Models: Were like a video game with low graphics. You could see the plane (virus) fly, but you couldn't see the turbulence or the passengers (immune cells) reacting realistically.
• This New Model: Is a high-definition simulator with full physics. It allows scientists to watch the very first seconds of a viral attack in a human-like environment.

The Takeaway:
This research gives us a much better tool to study how viruses like the flu, RSV, or even future pandemics start their infection. By having a model that includes the "security team" and the "structural support," scientists can test new drugs and vaccines more accurately, potentially saving lives by finding cures that work in the real world, not just in a simple petri dish.

In short: They built a realistic, 3D, immune-equipped mini-nose, proved it fights the flu just like a real one, and showed us that the battle starts with the walls themselves, even before the security guards fully jump into action.

Technical Summary

1. Problem Statement

Respiratory infectious diseases remain a leading cause of global morbidity and mortality. While animal models and traditional in vitro systems (such as Air-Liquid Interface (ALI) cultures of bronchial epithelial cells) have advanced the understanding of respiratory viruses, they possess significant limitations:

• Animal Models: Often have low predictive value for human outcomes due to physiological differences.
• Traditional ALI Cultures: While they successfully mimic the differentiated respiratory epithelium (ciliated, goblet, and basal cells), they lack the complexity of the native tissue architecture. Specifically, they fail to include the lamina propria (connective tissue) and resident immune cells (such as macrophages), which are critical for studying early host-pathogen interactions, tissue repair, and innate immune responses.

2. Methodology

The authors developed a novel, immunocompetent 3D organotypic model of the human nasal respiratory mucosa using primary human cells and a biomimetic scaffold.

A. Cell Source and Preparation:

• Fibroblasts: Isolated from mid-turbinate nasal biopsies (connective tissue) and expanded.
• Epithelial Cells: Obtained via nasal brushings from patients undergoing surgery. These were expanded and differentiated into basal cells (p63+).
• Macrophages: Derived from human blood monocytes isolated from buffy coats, differentiated using Macrophage Colony-Stimulating Factor (M-CSF).

B. Scaffold Construction:

• A collagen-chitosan scaffold was created using Type I bovine collagen and chitosan dissolved in acetic acid, followed by lyophilization.
• This scaffold mimics the extracellular matrix (ECM) of the lamina propria, providing structural support and mechanical strength.

C. Model Assembly (Sequential Seeding):
The model was constructed over 14 weeks using a specific sequential seeding protocol:

1. Week 0: Fibroblasts seeded on one side of the scaffold to colonize the matrix.
2. Week 1: Fibroblasts seeded on the opposite side.
3. Week 5: Macrophages added to the fibroblast layer (creating an immunocompetent "lamina propria").
4. Week 6: Epithelial basal cells seeded on the top surface.
5. Week 7–14: After one week of submerged culture, the model was lifted to Air-Liquid Interface (ALI) conditions for 6 weeks to induce full epithelial differentiation (ciliated and goblet cells).

D. Experimental Validation:

• Histology: Staining for vimentin (fibroblasts), p63/CK19 (epithelium), acetylated tubulin (cilia), MUC5B (goblet cells), and CD68 (macrophages).
• Functional Assay: Measurement of ciliary beating frequency via time-lapse microscopy.
• Infection Model: The models were infected with Influenza A Virus (IAV, strain A/Nepal/921/2006) at a Multiplicity of Infection (MOI) of 1.
• Analysis: Viral replication was quantified via plaque assay and RT-qPCR. Innate immune responses were assessed by measuring cytokine/interferon levels in supernatants and gene expression (ISGs) in the tissue.

3. Key Contributions

• Immunocompetent Architecture: The study successfully integrated a fully differentiated respiratory epithelium with a fibroblast-rich lamina propria containing macrophages, a feature missing in standard ALI models.
• Physiological Relevance: The model recapitulates the structural organization of the human upper respiratory tract, including the basement membrane (indicated by $\alpha6$-integrin expression) and the mucociliary apparatus.
• Upper Airway Specificity: By using nasal-derived cells, the model specifically addresses the upper respiratory tract, which is the primary entry point for many viruses but is often underrepresented in lung-focused models.

4. Key Results

• Structural Integrity: The reconstructed mucosa displayed a pseudo-stratified epithelium with basal cells (p63+), ciliated cells (AcTub+), and goblet cells (MUC5B+). The lamina propria contained fibroblasts (vimentin+) and macrophages (CD68+).
• Functionality: The ciliary beating frequency averaged 12.2 Hz, falling within the physiological range (10–20 Hz) of human airway cilia.
• Viral Susceptibility: The model was highly permissive to IAV infection.
  • Viral nucleoprotein (NP) was detected in ciliated cells by 48 hours.
  • Viral titers in supernatants reached $10^5$ to $10^6$ PFU/mL at 48 hours, confirming active replication.
  • The presence of macrophages did not inhibit viral replication.
• Immune Response:
  • Infection triggered a robust innate immune response, characterized by increased secretion of pro-inflammatory cytokines (IL-6, IL-8, IL-1$\beta$, GM-CSF) and interferons (IFN-$\beta$, IFN-$\lambda$1, IFN-$\lambda$2).
  • Upregulation of Interferon-Stimulated Genes (ISGs) such as ISG15, RSAD2, MX1, and OAS1 was observed.
  • Macrophage Impact: Interestingly, the inclusion of macrophages did not significantly alter the magnitude of the cytokine/interferon response compared to models without macrophages, suggesting that in this specific system, epithelial cells and fibroblasts were the primary drivers of the early antiviral response.

5. Significance

This paper presents a significant advancement in respiratory disease modeling by bridging the gap between simple epithelial cultures and complex in vivo systems.

• Translational Value: The model offers a physiologically relevant platform for studying early host-pathogen interactions, drug delivery, and vaccine efficacy specifically in the context of the upper airway.
• 3R Principle: It supports the reduction, refinement, and replacement of animal models in research.
• Future Applications: The platform is suitable for investigating the mechanisms of emerging respiratory viruses, testing antiviral therapeutics, and dissecting the role of stromal and immune cells in mucosal immunity. The authors note that while the current macrophage integration showed limited modulation of the immune response, the model provides a foundation for further optimization to better mimic in vivo immune dynamics.